HealthCare Global Enterprises Ltd, The Specialist in Cancer Care, today organized a press conference at Hyderabad, on Robotic Radiosurgery for Urological Conditions.
Dr. G. Kilara, Senior Consultant, Radiation Oncologist, HCG, said, “The incidence of the prostate cancer is on the rise. Lifestyle factors have also contributed to this increase. Prostate cancer constitutes to 6% of all cancers in men. With the advancement in technology, we are now able to target the disease with larger doses of radiation, with sub-millimeter accuracy. Because of the organ motion, traditional methods of radiation had to treat a larger volume of tissue to achieve this and this meant increased dose to some of the normal surrounding structures. For Ex: Bladder, Rectum and Intestine. Robotic Whole Body Stereo Tactic Radio Surgery, tracks the organ motion in real time and directs radiation with sub millimeter precision at the tumor tissue. This is typically applicable in prostate cancer, where we effectively cure the disease, but spare the bladder and the rectum.”
He further adds, “Because of the high doses of radiation per sitting (Hypo Fractionation), the entire process of treatment can be completed in 8 to 10 days as opposed to 7 to 8 weeks with conventional treatments.”
It is the world’s first non-invasive whole body robotic radiosurgery. CyberKnife offers patients new hope for the treatment of tumours and lesions, including ones that previously have been diagnosed as inoperable or untreatable with the existing technology. CyberKnife uses state-of-the-art real-time image guidance, similar to cruise missile technology, to precisely target tumours anywhere in the body with pinpoint accuracy and delivers high doses of radiation.
Advantages of CyberKnife:
Non-invasive and pain-less
Treats inoperable tumors
Significantly reduces treatment time
Automatic movement tracking
No need for invasive body or head frame
Higher radiation dose possible
Minimises side effects
Health Care Global Enterprises Ltd, (HCG), The Specialist in Cancer Care, headquartered in Bangalore with over 23 cancer centers is South Asia’s largest cancer care network. HCG has defined the future of cancer care in India by designing, building and managing cancer care centres with a committed vision. HCG focuses on cancer care treatment, imaging and laboratory services, clinical trials and research services. The vision of HCG is to make high quality cancer care accessible by adopting global innovations to all segments of the society.